Literature DB >> 15469427

Novel HMBS founder mutation and significant intronic polymorphism in Spanish patients with acute intermittent porphyria.

E Guillén-Navarro1, P Carbonell, G Glover, M Sánchez-Solís, A Fernández-Barreiro.   

Abstract

Acute intermittent porphyria (AIP) is an autosomal dominant disorder of heme biosynthesis, caused by a partial deficiency of hydroxymethylbilane synthase (HMBS). Knowledge of the nature of the HMBS mutations causing AIP in Spanish families is very limited. Here we report a novel 669_698del of the HMBS gene in twenty-two individuals from five independent Spanish AIP families, settled in Murcia (southeastern region of Spain). All mutation carriers shared a common disease associated haplotype indicating an ancestral founder effect. Identification of the 669_698del founder mutation allowed rapid and simple molecular diagnosis of AIP in families from this region in Spain. In addition, 771 + 58C>T in intron 12 on the non-669_698del allele was identified in six AIP patients, which promoted homozygous AIP misdiagnosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15469427     DOI: 10.1046/j.1529-8817.2003.00114.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  7 in total

1.  Marked geographic aggregation of acute intermittent porphyria families carrying mutation Q180X in Venezuelan populations, with description of further mutations.

Authors:  Irene Paradisi; Sergio Arias
Journal:  J Inherit Metab Dis       Date:  2010-10-27       Impact factor: 4.982

2.  Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation.

Authors:  J To-Figueras; C Badenas; C Carrera; C Muñoz; M Milá; M Lecha; C Herrero
Journal:  J Inherit Metab Dis       Date:  2006-08       Impact factor: 4.982

Review 3.  Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes.

Authors:  Makiko Yasuda; Brenden Chen; Robert J Desnick
Journal:  Mol Genet Metab       Date:  2018-11-30       Impact factor: 4.797

4.  High penetrance of acute intermittent porphyria in a Spanish founder mutation population and CYP2D6 genotype as a susceptibility factor.

Authors:  María Barreda-Sánchez; Juan Buendía-Martínez; Guillermo Glover-López; Carmen Carazo-Díaz; María Juliana Ballesta-Martínez; Vanesa López-González; María José Sánchez-Soler; Lidya Rodriguez-Peña; Ana Teresa Serrano-Antón; Remedios Gil-Ferrer; Maria Del Carmen Martínez-Romero; Pablo Carbonell-Meseguer; Encarna Guillén-Navarro
Journal:  Orphanet J Rare Dis       Date:  2019-02-26       Impact factor: 4.123

5.  Health impact of acute intermittent porphyria in latent and non-recurrent attacks patients.

Authors:  Juan Buendía-Martínez; María Barreda-Sánchez; Lidya Rodríguez-Peña; María Juliana Ballesta-Martínez; Vanesa López-González; María José Sánchez-Soler; Ana Teresa Serrano-Antón; María Elena Pérez-Tomás; Remedios Gil-Ferrer; Francisco Avilés-Plaza; Guillermo Glover-López; Carmen Carazo-Díaz; Encarna Guillén-Navarro
Journal:  Orphanet J Rare Dis       Date:  2021-02-27       Impact factor: 4.123

6.  Anthropometric and Quality-of-Life Parameters in Acute Intermittent Porphyria Patients.

Authors:  Antonia M Jiménez-Monreal; MAntonia Murcia; Victoria Gómez-Murcia; Maria Del Mar Bibiloni; Antoni Pons; Josep A Tur; Magdalena Martínez-Tomé
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

7.  Molecular Analysis of 55 Spanish Patients with Acute Intermittent Porphyria.

Authors:  María-José Morán-Jiménez; María-José Borrero-Corte; Fátima Jara-Rubio; Inmaculada García-Pastor; Silvia Díaz-Díaz; Francisco-Javier Castelbón-Fernandez; Rafael Enríquez-de-Salamanca; Manuel Méndez
Journal:  Genes (Basel)       Date:  2020-08-12       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.